ICD-10 Coding for Children's Oncology Group Impairment(C91.00, G31.84)
Complete ICD-10-CM coding and documentation guide for Children's Oncology Group Impairment. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Children's Oncology Group Impairment
Cognitive deficits
Used for cognitive deficits not directly linked to structural changes
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C91.00 | Acute lymphoblastic leukemia, not having achieved remission | Use when diagnosing a child with ALL as the primary condition |
|
| G31.84 | Mild cognitive impairment, so stated | Use when cognitive impairment is directly linked to cancer treatment |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for cognitive impairment in pediatric cancer
Essential facts and insights about Children's Oncology Group Impairment
Primary ICD-10-CM Codes for children's oncology group impairment
Decision Criteria
clinical Criteria
- Confirmed diagnosis of ALL via bone marrow biopsy
Applicable To
- ALL diagnosis
Excludes
- Chronic leukemia
Clinical Validation Requirements
- Bone marrow biopsy confirming ALL
- Peripheral blood smear
Code-Specific Risks
- Misclassification if remission status is not documented
Coding Notes
- Ensure remission status is clearly documented
G31.84 - Mild cognitive impairment, so stated
Use when cognitive impairment is directly linked to cancer treatment
Applicable To
- Chemotherapy-induced cognitive impairment
Excludes
- Dementia
Clinical Validation Requirements
- Neuropsychological testing showing cognitive decline
- MRI showing leukoencephalopathy
Coding Notes
Link cognitive impairment to specific treatment cycles
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Children's Oncology Group Impairment to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C91.00.
Impact
Clinical: Misrepresentation of patient's condition, Regulatory: Potential audit failure, Financial: Loss of reimbursement
Mitigation Strategy
Use standardized templates, Regular training on documentation standards
Impact
Reimbursement: Potential underpayment due to lack of specificity, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation Strategy
Use G31.84 with supporting documentation
Impact
Risk of incorrect coding without proper documentation
Mitigation Strategy
Ensure all documentation links cognitive issues to treatment
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Children's Oncology Group Impairment, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Children's Oncology Group Impairment
Use these documentation templates to ensure complete and accurate documentation for Children's Oncology Group Impairment. These templates include all required elements for proper coding and billing.
Pediatric oncology follow-up
Specialty: Pediatric OncologyRequired Elements
- Cognitive assessment results
- MRI findings
- Treatment history
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Children's Oncology Group Impairment? Ask your questions below.